Seegene, Inc.

Taewon Bldg., 91 Ogeum-ro, Songpa-Gu
Seoul,  05548

Korea (South)


Seegene, as a leader in multiplex molecular diagnostics, is committed to supporting the global response to the rapidly evolving COVID-19. The unveiled Seegene’s complete solution for COVID-19 detects and differentiates SARS-CoV-2, influenza, RSV, and other common respiratory pathogens in one integrated platform. Its accurate and reliable test results help reduce further spread of SARS-CoV-2 and provide right information for effective management of influenza-like illness patients. With Seegene’s core technology and proprietary know-how, we offer multiple diagnostics solutions for infectious diseases, including common respiratory infections, gastrointestinal tract infections, meningitis, HPV, and STIs.



 Corporate, Product or Service Images


  • Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay
    Primary screening for SARS-CoV-2, Flu A, Flu B and RSV A/B in one tube...

  • - One tube test for Flu A, Flu B, RSV A/B, and three different target genes of SARS-CoV-2 along with dual control

    - Selected three targets of genes - N gene, RdRP gene, and S gene - from WHO references for SARS-CoV-2

    - Self-collected specimen availability

    - High-throughput testing with an automated platform

    - Quick and easy data analysis and interpretation

    * This assay is intended for in vitro diagnostic use in Europe. Not available in all countries. Pending FDA authorization

  • Allplex™ SARS-CoV-2/Flu/RSV Assay
    One tube multiplex real-time PCR assay to differentiate SARS-CoV-2, Flu and RSV....

  • - One tube test for SARS-CoV-2, Flu, and RSV along with an exogenous internal control

    - High-throughput testing with an automated platform

    - Expand applicable real-time PCR instrument (AB7500 Fast Dx)

    - Quick and easy data analysis and interpretation

    * Pending FDA authorization